The Top 60: HC&B Healthcare Communications

HC&B Healthcare's tagline is “See What Healthcare Can Be.” Given the astonishing diversity of its services and clients, the phrase could just as easily read “See What a Healthcare Agency Can Be.”
Since its unfortunately timed launch (on Sept. 10, 2001), HC&B has grown by 20-25% a year and thrives on a smorgasbord of projects—print advertisements, DTC, web development, interactive gaming, online tools—for pharma companies, healthcare insurers, device and diagnostics firms and physician groups.

“We came along after the big pharma boom,” says CEO Kerry Hilton, “And by expanding the healthcare category we have been able to sustain growth.”

HC&B has reinforced its creative reputation, taking home numerous awards in 2007 and 2008.
“We have a passion for looking at things through a very different lens,” says Hilton.

And as the industry's lone star of Austin, TX, the firm has a geographic edge when it comes to winning local business and tapping Texas talent. “We've gotten several phone calls from major institutions from around [the state] who are looking for a provider closer to home,” notes Hilton.

Spurred on by some major international projects, Hilton plans to extend HC&B's global reach and is in the final stages of acquiring a small London shop.

Meanwhile, Hilton is confident HC&B will continue to flourish domestically. “We have transformed into a healthcare agency with a unique purpose and vision, and unique roots,” he says. “We're not competing against the Dale Taylors and the Palios,” he says. “But hopefully in 12 months we will be.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.